PRA Health Sciences (PRAH) Tops Q2 EPS by 4c, Revenues Beat Offers FY18 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PRA Health Sciences, Inc. Reports Second Quarter 2018 Results and Updates Full Year 2018 Guidance
August 1, 2018 4:00 PM EDTNet new business of $670.0 million; Net book-to-bill of 1.30$722.8 million of revenue; 35.4% growth at actual foreign exchange rates and 34.2% growth on a constant currency basis$575.0 million of revenue excluding the impact of ASC 606; 25.6% actual growth and 12.9% organic growth at actual foreign exchange rates; 24.4% growth and 11.7% organic growth on a constant currency basisGAAP net income per diluted share of $0.64 and GAAP net income of $42.0 millionAdjusted net income per diluted share was $1.00 and adjusted net income was $66.1 millionUpdating full year 2018 revenue guidance between $2.87 billion... More
